Although our patient had no radiographic evidence of additional intra-pancreatic or distant metastatic disease, he remains at significant risk for additional or recurrent disease due to his known multifocal disease and MEN1 mutation and will require close follow-up. This evidence concerns the gene MEN1 and metastatic neoplasm.